文献速递传染病防控与疫情报告卫生政策与健康促进

人群与检测特征在基于抗原的SARS-CoV-2诊断中的作用,捷克,2021年8月至11月

Role of population and test characteristics in antigen-based SARS-CoV-2 diagnosis, Czechia, August to November 2021.
PubMed 文献 · Euro Surveill · 2022-01-01

该研究基于捷克2021年8月至11月传染病信息系统中346,000条抗原快速诊断检测(AG-RDT)结果及3日内PCR确认数据,分析AG-RDT在不同亚组中的敏感性与特异性。平均敏感性72.4%、特异性96.7%,敏感性随年龄、发病率、样本类型、检测原因、症状及疫苗状态而异;作者认为应考虑使用获批清单上的AG-RDT,结果限于SARS-CoV-2 delta变异株。

要点

  • 平均敏感性72.4%、特异性96.7%(346,000条AG-RDT结果)。
  • 0-12岁和13-18岁敏感性较低,分别为65.5%和65.3%。
  • 有症状者敏感性84.8%,无症状者57.1%;预防性检测63.6%,疑似感染检测86.1%。

核心结论

  • 应考虑使用获批清单上的AG-RDT,尤其是在与较低病毒载量相关的情形中。
  • 结果仅限于SARS-CoV-2 delta变异株。

研究设计与样本

  • 纳入捷克传染病信息系统2021年8月至11月登记的AG-RDT结果。
  • 基于346,000条AG-RDT结果且AG-RDT后≤3天有PCR确认记录进行亚组分析。
  • 对38种AG-RDT(每种有超过100份PCR阳性和300份PCR阴性样本)进行单独评估。

主要发现

  • 平均敏感性和特异性分别为72.4%和96.7%。
  • 0-12岁组敏感性65.5%,13-18岁组敏感性65.3%。
  • 敏感性随SARS-CoV-2发病率升高从66.0%升至76.7%。
  • 鼻咽拭子敏感性最高,唾液敏感性最低。
  • 预防性检测敏感性63.6%,疑似感染检测敏感性86.1%;有≥1种症状时敏感性84.8%,无症状时57.1%。

关键数值与推荐

  • 平均敏感性72.4%,平均特异性96.7%(346,000条AG-RDT结果)。
  • 0-12岁敏感性65.5%,13-18岁敏感性65.3%。
  • 发病率升高时敏感性从66.0%升至76.7%。
  • 预防性检测敏感性63.6% vs 疑似感染检测86.1%。
  • 有症状敏感性84.8% vs 无症状57.1%;接种疫苗与敏感性升高4.2%相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 结果仅限于SARS-CoV-2 delta变异株。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BackgroundAnalyses of diagnostic performance of SARS-CoV-2 antigen rapid diagnostic tests (AG-RDTs) based on long-term data, population subgroups and many AG-RDT types are scarce.AimWe aimed to analyse sensitivity and specificity of AG-RDTs for subgroups based on age, incidence, sample type, reason for test, symptoms, vaccination status and the AG-RDT's presence on approved lists.MethodsWe included AG-RDT results registered in Czechia's Information System for Infectious Diseases between August and November 2021. Subpopulations were analysed based on 346,000 test results for which a confirmatory PCR test was recorded ≤ 3 days after the AG-RDT; 38 AG-RDTs with more than 100 PCR-positive and 300 PCR-negative samples were individually evaluated.ResultsAverage sensitivity and specificity were 72.4% and 96.7%, respectively. We recorded lower sensitivity for age groups 0-12 (65.5%) and 13-18 years (65.3%). The sensitivity level rose with increasing SARS-CoV-2 incidence from 66.0% to 76.7%. Nasopharyngeal samples had the highest sensitivity and saliva the lowest. Sensitivity for preventive reasons was 63.6% vs 86.1% when testing for suspected infection. Sensitivity was 84.8% when one or more symptoms were reported compared with 57.1% for no symptoms. Vaccination was associated with a 4.2% higher sensitivity. Significantly higher sensitivity levels pertained to AG-RDTs on the World Health Organization Emergency Use List (WHO EUL), European Union Common List and the list of the United Kingdom's Department of Health and Social Care.ConclusionAG-RDTs from approved lists should be considered, especially in situations associated with lower viral load. Results are limited to SARS-CoV-2 delta variant.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Kliegr T, Jarkovský J, Jiřincová H, et al. Role of population and test characteristics in antigen-based SARS-CoV-2 diagnosis, Czechia, August to November 2021. Euro Surveill. 2022. PMID: 35983773. doi:10.2807/1560-7917.ES.2022.27.33.2200070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。